The bladder cancer immune micro-environment in the context of response to immune checkpoint inhibition

Treatment with neoadjuvant cisplatin-based chemotherapy followed by radical cystectomy is the default treatment for muscle-invasive bladder cancer (BC). However, with the encouraging results of immune checkpoint inhibitiors (ICI) directed against PD-1/PD-L1 and CTLA-4 in recent years, the treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: van Dorp, Jeroen, van der Heijden, Michiel S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505825/
https://www.ncbi.nlm.nih.gov/pubmed/37727793
http://dx.doi.org/10.3389/fimmu.2023.1235884

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505825/
https://www.ncbi.nlm.nih.gov/pubmed/37727793
http://dx.doi.org/10.3389/fimmu.2023.1235884

Ejemplares similares